ArticleBioinformatics (Oxford, England)2026
Mamba6mA: a Mamba-based DNA N6-methyladenine site prediction model.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- ToxMamba: a novel method for toxic peptide prediction based on the fusion of pretrained embeddings and multi-scale state space models.Briefings in bioinformatics · 2026Article
- Deep learning-based identification of N6-methyladenine sites via hybrid feature fusion and SHAP-driven feature selection.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
motivationN6-methyladenine (6 mA) is an important epigenetic modification of DNA that regulates biological processes such as gene expression, transcription, replication, DNA repair, and cell cycle without altering the DNA sequence. It also plays a key role in many diseases including cancer and autoimmune diseases. Although experimental approaches such as SMRT sequencing and methylated DNA immunoprecipitation can identify 6 mA sites, they suffer from drawbacks including suboptimal sequencing quality, low signal-to-noise ratios, high costs, and time-consuming procedures. In recent years, deep learning approaches have demonstrated significant advantages in predicting 6 mA sites; however, their generalization ability still requires further improvement.
resultsInspired by the state space model Mamba, we propose a novel model for 6 mA site prediction, named Mamba6mA. In the Mamba6mA model, we design position-specific linear layers to replace traditional convolutional layers to facilitate capture specific positional information. Meanwhile, we construct a multi-scale feature extraction module and integrate features captured by sliding windows of different scales, feeding them into the classifier for prediction. Experimental results show that Mamba6mA achieves the best MCC on 9 out of 11 species datasets, surpassing existing state-of-the-art models. Ablation studies confirm that the position-specific linear layers and the multi-scale fusion module contribute MCC performance gains of 2.36% and 2.31%, respectively. Feature visualization analysis further reveals that the model effectively captures sequence patterns upstream and downstream of 6 mA sites providing a new technical approach for studying epigenetic modification mechanisms. AVAILABILITY AND IMPLEMENTATION: The source code for Mamba6mA is available at: https://github.com/XploreAI-Lab/Mamba6mA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.